BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9589239)

  • 1. Use of the therapeutic footwear benefit among diabetic medicare beneficiaries in three states, 1995.
    Sugarman JR; Reiber GE; Baumgardner G; Prela CM; Lowery J
    Diabetes Care; 1998 May; 21(5):777-81. PubMed ID: 9589239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motivational brochures increase the number of medicare-eligible persons with diabetes making therapeutic footwear claims.
    LeMaster JW; Sugarman JR; Baumgardner G; Reiber GE
    Diabetes Care; 2003 Jun; 26(6):1679-84. PubMed ID: 12766093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foot care practices, services and perceptions of risk among medicare beneficiaries with diabetes at high and low risk for future foot complications.
    Harwell TS; Helgerson SD; Gohdes D; McInerney MJ; Roumagoux LP; Smilie JG
    Foot Ankle Int; 2001 Sep; 22(9):734-8. PubMed ID: 11587391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of therapeutic footwear on foot reulceration in patients with diabetes: a randomized controlled trial.
    Reiber GE; Smith DG; Wallace C; Sullivan K; Hayes S; Vath C; Maciejewski ML; Yu O; Heagerty PJ; LeMaster J
    JAMA; 2002 May; 287(19):2552-8. PubMed ID: 12020336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of expenditures and use of services among older adults with diabetes. Implications for the transition to capitated managed care.
    Krop JS; Powe NR; Weller WE; Shaffer TJ; Saudek CD; Anderson GF
    Diabetes Care; 1998 May; 21(5):747-52. PubMed ID: 9589235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrative review of therapeutic footwear for neuropathic foot due to diabetes mellitus.
    Igiri BE; Tagang JI; Okoduwa SIR; Adeyi AO; Okeh A
    Diabetes Metab Syndr; 2019; 13(2):913-923. PubMed ID: 31336545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonoperative care to manage sacroiliac joint disruption and degenerative sacroiliitis: high costs and medical resource utilization in the United States Medicare population.
    Ackerman SJ; Polly DW; Knight T; Holt T; Cummings J
    J Neurosurg Spine; 2014 Apr; 20(4):354-63. PubMed ID: 24527824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal Trends in Heart Failure Incidence Among Medicare Beneficiaries Across Risk Factor Strata, 2011 to 2016.
    Khera R; Kondamudi N; Zhong L; Vaduganathan M; Parker J; Das SR; Grodin JL; Halm EA; Berry JD; Pandey A
    JAMA Netw Open; 2020 Oct; 3(10):e2022190. PubMed ID: 33095250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in merging Medicaid and Medicare databases to obtain healthcare costs for dual-eligible beneficiaries: using diabetes as an example.
    Prela CM; Baumgardner GA; Reiber GE; McFarland LV; Maynard C; Anderson N; Maciejewski M
    Pharmacoeconomics; 2009; 27(2):167-77. PubMed ID: 19254049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing diabetic foot disease: lessons from the Medicare therapeutic shoe demonstration.
    Wooldridge J; Bergeron J; Thornton C
    Am J Public Health; 1996 Jul; 86(7):935-8. PubMed ID: 8669516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRENDS IN THE CARE AND OUTCOMES OF MEDICARE BENEFICIARIES WITH TYPE 2 DIABETES, 2002-2011.
    Hyland KA; Greiner MA; Qualls LG; Califf RM; Hernandez AF; Curtis LH
    Endocr Pract; 2016 Aug; 22(8):920-34. PubMed ID: 27042746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors in diabetic footwear compliance.
    Macfarlane DJ; Jensen JL
    J Am Podiatr Med Assoc; 2003; 93(6):485-91. PubMed ID: 14623991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare utilization and cost burden of Huntington's disease among Medicare beneficiaries in the United States.
    Exuzides A; Reddy SR; Chang E; Ta JT; Patel AM; Paydar C; Yohrling GJ
    J Med Econ; 2021; 24(1):1327-1336. PubMed ID: 34730477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the costs to Medicare of covering therapeutic shoes for diabetic patients.
    Wooldridge J; Moreno L
    Diabetes Care; 1994 Jun; 17(6):541-7. PubMed ID: 8082522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic rate estimation from Medicare records: Dependence on claim numbers and latent clinical features.
    Hogans B; Siaton B; Sorkin J
    J Biomed Inform; 2023 Sep; 145():104463. PubMed ID: 37517509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to shop for shoes. If you have diabetes, footwear is more than a fashion statement. Here are some tips for buying the right pair of shoes.
    Scheffler NM
    Diabetes Forecast; 2004 Mar; 57(3):70-3. PubMed ID: 15017921
    [No Abstract]   [Full Text] [Related]  

  • 17. Identifying Medicare Beneficiaries Accessing Transgender-Related Care in the Era of ICD-10.
    Ewald ER; Guerino P; Dragon C; Laffan AM; Goldstein Z; Streed C
    LGBT Health; 2019; 6(4):166-173. PubMed ID: 31084519
    [No Abstract]   [Full Text] [Related]  

  • 18. Perceived usability and use of custom-made footwear in diabetic patients at high risk for foot ulceration.
    Arts ML; de Haart M; Bus SA; Bakker JP; Hacking HG; Nollet F
    J Rehabil Med; 2014 Apr; 46(4):357-62. PubMed ID: 24356801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. For diabetes ... a reminder of footwear benefits.
    Health News; 1998 Jul; 4(9):5. PubMed ID: 9693448
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting expenditures for Medicare beneficiaries with diabetes. A prospective cohort study from 1994 to 1996.
    Krop JS; Saudek CD; Weller WE; Powe NR; Shaffer T; Anderson GF
    Diabetes Care; 1999 Oct; 22(10):1660-6. PubMed ID: 10526731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.